Home

Subscription

December 2024 issue

November 2024 issue

October 2024 issue

September 2024 issue

August 2024 issue

July 2024 issue

June 2024 issue

May 2024 issue

April 2024 issue

April 1, 2024 issue

March 2024 issue

February 2024 issue

January 2024 issue



BACK ISSUES

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2009 Issues

December 2009 Issue
• Feature - No Vacancy*
• Congratulations and Appreciation!
• Editor's Note
• New therapeutic agents marketed in the United States in 2009
• The Top 10 New Drugs of the Decade (Millenium)


November 2009 Issue
• Feature - What are they Doing to our Profession? - And Who Cares?
• New Drug Review - Dronedarone (Multaq - Sanofi-Aventis)


October 2009 Issue
• Feature - The Influenza Follies
• New Drug Review - Saxagliptin hydrochloride (Onglyza - Bristol-Myers Squibb; AstraZeneca)


September 2009 Issue
• Feature - Prescription Benefit Programs - Classes of Pharmacies Should be Established
• New Drug Review - Prasugrel hydrochloride (Effient - Daiichi Sankyo; Lilly) Antiplatelet Agent


August 2009 Issue
• Feature - Addiction Pharmacy Should Assume a Leadership Role in Addressing this Devastating Problem!
• New Drug Review - Tapentadol hydrochloride (Nucynta - PriCara) Analgesic


July 2009 Issue
• Feature - The Acetaminophen Challenge (and Recommendations)
• New Drug Review - Lacosamide (Vimpat - UCB)


June 2009 Issue
• Feature - Prescription Benefit Programs - A New Model IS Needed!
• New Drug Review - Besifloxacin hydrochloride (Besivance - Bausch & Lomb)


May 2009 Issue
• Feature - CVS Caremark - An Alliance that Must be Broken
• New Drug Review - Golimumab (Simponi - Centocor Ortho Biotech)


April 2009 Issue
• Feature - Dear Legislator
• New Drug Review - Febuxostat (Uloric - Takeda)


March 2009 Issue
• Feature - Coupons, $4 generics, and Free Generic Antibiotics - Disservices to Patients and Insults to Pharmacists
• New Drug Review - Silodosin (Rapaflo - Watson)


February 2009 Issue
• Feature - Pfizer Should Not be Permitted to Acquire Wyeth!
• New Drug Review - Milnacipran hydrochloride (Savella - Forest; Cypress)


January 2009 Issue
• Feature - A New Year, an Old Theme Can our National Pharmacy Associations Reach Nome?
• New Drug Review - Fesoterodine fumarate (Toviaz - Pfizer)